Pharmaceuticals

Global Shingles Vaccine Market Report 2026–2035: Key Forecasts and Growth Areas

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the shingles vaccine market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Shingles Vaccine Market covering 2026–2035?

The shingles vaccine market has experienced rapid expansion in recent years. It is projected to grow from $5.55 billion in 2025 to $6.37 billion in 2026, driven by a compound annual growth rate (CAGR) of 14.8%. This market’s historical growth can be attributed to factors such as the limited availability of shingles vaccines, a reliance on live attenuated vaccines, a growing elderly population, an increasing incidence of herpes zoster, and rising awareness regarding the benefits of immunization.

The shingles vaccine market size is projected for substantial expansion in the coming years. It is forecast to achieve $10.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 14.5%. This growth over the forecast period stems from various factors, including the advancement of recombinant and subunit vaccines, the broadening of public and private vaccination efforts, increased uptake of online and retail pharmacy distribution channels, intensified government and healthcare initiatives aimed at elderly immunization, and the integration of digital health monitoring to support vaccination adherence. Significant trends anticipated during this period involve the rising adoption of recombinant and subunit shingles vaccines, enhanced awareness among older adults regarding shingles prevention, the expansion of vaccination programs through hospital and retail pharmacies, the development of online pharmacies and e-commerce for vaccine distribution, and a concentrated focus on age-specific immunization strategies for the 50+ population.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27413&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Shingles Vaccine Market?

A rise in vaccination programs is anticipated to fuel expansion within the shingles vaccine market in the future. These programs are structured public health efforts focused on systematically delivering vaccines to populations to curb the spread of infectious illnesses. The surge in vaccination programs stems from heightened awareness of preventative health measures, motivating a greater number of individuals to seek immunization against diseases. They boost the uptake of the shingles vaccine by improving public understanding and availability, rendering them particularly suitable for older adults and demographics at higher risk. Such programs mitigate the likelihood of shingles and its associated complications through encouraging prompt and extensive immunization, thereby enhancing general community well-being. As an illustration, in July 2025, the World Health Organization, an intergovernmental body situated in Switzerland, reported that the coverage for the initial dose of the human papillomavirus (HPV) vaccine among girls rose from 27% in 2023 to 31% in 2024. Consequently, the expanding quantity of vaccination programs is propelling the advancement of the shingles vaccine market.

What Segments Are Identified Within The Structure Of The Shingles Vaccine Market?

The shingles vaccine market covered in this report is segmented –

1) By Vaccine Type: Live Attenuated Vaccine, Recombinant Vaccine, Subunit Vaccine

2) By Product: Shingrix, Zostavax, Skyzoster

3) By Age Group: 50-59 Years, 60-69 Years, 70 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

5) By End User: Hospitals, Clinics, Pharmacies

Subsegments:

1) By Live Attenuated Vaccine: Virus Strain A, Virus Strain B, Virus Strain C

2) By Recombinant Vaccine: Recombinant Protein Vaccine, Recombinant Vector Vaccine, Recombinant Deoxyribonucleic Acid Vaccine

3) By Subunit Vaccine: Protein Subunit Vaccine, Conjugate Subunit Vaccine

Which Trends Are Shaping Activity Within The Shingles Vaccine Market?

Leading companies in the shingles vaccine market are concentrating on developing innovative vaccine formulations, such as recombinant adjuvanted vaccines, to strengthen immune response and offer prolonged protection against shingles. Recombinant adjuvanted vaccines incorporate laboratory-produced viral proteins alongside substances called adjuvants to amplify the body’s immune reaction for more effective and enduring safeguarding. For instance, in April 2023, GlaxoSmithKline Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Shingrix, a shingles vaccine. Shingrix is a non-live, recombinant adjuvanted subunit vaccine administered intramuscularly in two doses for adults aged 50 and above, specifically designed to prevent shingles (herpes zoster) and its related complication, post-herpetic neuralgia. This highly effective vaccine provides over 90% protection against shingles, with robust and sustained immunity lasting at least 10 years, even in older adults and immunocompromised individuals.

Which Key Players Are Driving Competition In The Shingles Vaccine Market?

Major companies operating in the shingles vaccine market are Merck & Co. Inc., GSK plc, SK bioscience, Pfizer Inc, GeneOne Life Science, Curevo Inc, Novavax Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/shingles-vaccine-global-market-report

Which Region Is Projected To Lead The Shingles Vaccine Market During The Forecast Period?

North America was the largest region in the shingles vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingles vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Shingles Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27413&type=smp

Browse Through More Reports Similar to the Global Shingles Vaccine Market 2026, By The Business Research Company

Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-global-market-report

Folding Furniture Market Report 2026

https://www.thebusinessresearchcompany.com/report/folding-furniture-global-market-report

Foldable Houses Market Report 2026

https://www.thebusinessresearchcompany.com/report/foldable-houses-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795